FDA
-
-
-
-
-
-
-
iCAD’s ProFound AI Can Predict 1-2 Year Risk for Breast Cancer and Reveal Insights for Heart Disease
-
-
-
-
-
-
-
iCAD’s “ProFound Insights, ProFound Impact” Webinar Series to Feature Cleveland Clinic
-
-
-
-
-
-
-
iCAD to Join Forces with Radiology Partners, the Nation’s Largest Radiology Practice
-
-
-
-
-
-
-
iCAD Announces Additional Patients Treated Under GLIOX Trial and Continued Global Momentum for Xoft Intraoperative Radiation Therapy (IORT) for Brain, Rectal, Head and Neck Tumor Treatment
-
-
-
-
-
-
-
iCAD Announces Compelling New and Real-World Data Demonstrating the Value of ProFound AI to be Presented at RSNA 2021
-
-
-
-
-
-
-
iCAD Signs Global Distribution Agreement with Sectra
-
-
-
-
-
-
-
Pre-Open Stock Movers 03/16: (ENZ) (SVRA) (ANVS) Higher; (GME) (CLSK) (RUN) Lower (more...)
-
251,413 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All